New York S08380 requires covered entities to report to the Department of Health about 340B drug discounts and the percentage of patients benefiting.
New York S08380 amends the public health law to mandate that covered entities report to the Department of Health regarding certain 340B drug discounts and the percentage of patients benefiting from such discounts. The report must include details such as the total acquisition costs for 340B drugs, the total number of prescriptions filled with 340B drugs, and the percentage of patients served by a sliding fee scale for 340B drugs at the point of sale for low-income patients.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.